Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-005464
Filing Date
2015-09-28
Accepted
2015-09-28 21:00:25
Documents
2
Period of Report
2015-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1502
2 EX-24 DOCUMENT attachment1.htm EX-24 4156
  Complete submission text file 0000899243-15-005464.txt   7132
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Issuer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
McDonough Cameron Geoffrey (Reporting) CIK: 0001579130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 151128709